Non-nuclear-initiated actions of the estrogen receptor protect cortical bone mass

Molecular Endocrinology

Volumn 27, Issue 4, 2013, Pages 649-656

  Bartell, Shoshana M ^a   Han, Li ^a   Kim, Ha Neui ^a   Kim, Sung Hoon ^e   Katzenellenbogen, John A ^b   Katzenellenbogen, Benita S ^c   Chambliss, Ken L ^d   Shaul, Philip W ^d   Roberson, Paula K ^a   Weinstein, Robert S ^a   Jilka, Robert L ^a   Almeida, Maria ^a   Manolagas, Stavros C ^a  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b UNIVERSITY OF ILLINOIS AT URBANA CHAMPAIGN   (United States)

^c UNIVERSITY OF ILLINOIS AT URBANA CHAMPAIGN   (United States)

^d UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^e NONE

Author keywords

[No Author keywords available]

Indexed keywords

17BETA ESTRADIOL DENDRIMER CONJUGATE; CONJUGATED ESTROGEN; ESTROGEN RECEPTOR ALPHA; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL CELL CULTURE; ANIMAL EXPERIMENT; ANTIOXIDANT ACTIVITY; ARTICLE; BONE CHARACTERISTICS AND FUNCTIONS; BONE DENSITY; BONE MASS; CELL PROTECTION; CORTICAL BONE; DUAL ENERGY X RAY ABSORPTIOMETRY; FEMALE; FEMUR; IMAGE ANALYSIS; MICRO-COMPUTED TOMOGRAPHY; MOUSE; NONHUMAN; OSTEOBLASTOGENESIS; OSTEOCLASTOGENESIS; OSTEOLYSIS; OVARIECTOMY; OXIDATIVE STRESS; PRIORITY JOURNAL; RNA ANALYSIS; SPINE; UTERUS WEIGHT;

ANIMALS; ATROPHY; BONE AND BONES; BONE DENSITY; BONE REMODELING; CELL NUCLEUS; ESTRADIOL; ESTROGEN RECEPTOR ALPHA; FEMALE; FEMUR; MICE; MICE, INBRED C57BL; ORGAN SIZE; OSTEOCLASTS; OSTEOGENESIS; OVARIECTOMY; OXIDATIVE STRESS; SPINE; UTERUS;

MURINAE;

EID: 84875535167     PISSN: 08888809     EISSN: None     Source Type: Journal    
DOI: 10.1210/me.2012-1368     Document Type: Article

References (45)

1. Tsai MJ, O'Malley BW. Molecular mechanisms of action of steroid/thyroid receptor superfamily members. Annu Rev Biochem. 1994; 86:451-486.
2. Hammes SR, Levin ER. Minireview: recent advances in extranuclear steroid receptor actions. Endocrinology. 2011;152:4489-4495.
3. Kousteni S, Bellido T, Plotkin LI, et al. Nongenotropic, sexnonspecific signaling through the estrogen or androgen receptors: dissociation from transcriptional activity. Cell. 2001;104:719-730.
4. Kousteni S, Han L, Chen J-R, et al. Kinase-mediated regulation of common transcription factors accounts for the bone-protective effects of sex steroids. J Clin Invest. 2003;111:1651-1664.
5. Madak-Erdogan Z, Kieser KJ, Kim SH, Komm B, Katzenellenbogen JA, Katzenellenbogen BS. Nuclear and extranuclear pathway inputs in the regulation of global gene expression by estrogen receptors. Mol Endocrinol. 2008;22:2116-2127.
6. Manolagas SC, Kousteni S, Chen JR, Schuller M, Plotkin L, Bellido T. Kinase-mediated transcription, activators of nongenotropic estrogen-like signaling (ANGELS), and osteoporosis: a different perspective on the HRT dilemma. Kidney Int Suppl. 2004;91:S41-S49.
7. Kousteni S, Chen JR, Bellido T, et al. Reversal of bone loss in mice by nongenotropic signaling of sex steroids. Science. 2002;298:843-846.
8. Manolagas SC, Kousteni S. Perspective: nonreproductive sites of action of reproductive hormones. Endocrinology. 2001;142:2200-2204.
9. Windahl SH, Galien R, Chiusaroli R, et al. Bone protection by estrenes occurs through non-tissue-selective activation of the androgen receptor. J Clin Invest. 2006;116:2500-2509.
10. Manolagas SC, Jilka RL, Kousteni S, et al. Response to Windahl et al. J Clin Invest. 2006;116:2834.
11. Page ST, Marck BT, Tolliver JM, Matsumoto AM. Tissue selectivity of the anabolic steroid, 19-nor-4-androstenediol-3β;,17β;-diol in male Sprague Dawley rats: selective stimulation of muscle mass and bone mineral density relative to prostate mass. Endocrinology. 2008;149:1987-1993.
12. Wessler S, Otto C, Wilck N, Stangl V, Fritzemeier KH. Identification of estrogen receptor ligands leading to activation of nongenomic signaling pathways while exhibiting only weak transcriptional activity. J Steroid Biochem Mol Biol. 2006;98:25-35.
13. Otto C, Fuchs I, Altmann H, et al. In vivo characterization of estrogen receptor modulators with reduced genomic versus nongenomic activity in vitro. J Steroid Biochem Mol Biol. 2008;111:95-100.
14. Manolagas SC. Birth and death of bone cells: basic regulatory mechanisms and implications for the pathogenesis and treatment of osteoporosis. Endocr Rev. 2000;21:115-137.
15. Manolagas SC. From estrogen-centric to aging and oxidative stress: a revised perspective of the pathogenesis of osteoporosis. Endocr Rev. 2010;31:266-300.
16. Riggs BL, Khosla S, Melton LJ III. Sex steroids and the construction and conservation of the adult skeleton. Endocr Rev. 2002;23:279-302.
17. Manolagas SC, Kousteni S, Jilka RL. Sex steroids and bone. Recent Prog Horm Res. 2002;57:385-409.
18. Martin-Millan M, Almeida M, Ambrogini E, et al. The estrogen receptor alpha in osteoclasts mediates the protective effects of estrogens on cancellous but not cortical bone. Mol Endocrinol. 2010; 24:323-334.
19. Nakamura T, Imai Y, Matsumoto T, et al. Estrogen prevents bone loss via estrogen receptor alpha and induction of Fas ligand in osteoclasts. Cell. 2007;130:811-823.
20. Almeida M, Iyer S, Martin-Millan M, et al. Estrogen receptor-alpha signaling in osteoblast progenitors stimulates cortical bone accrual. J Clin Invest. 2013;123:394-404.
21. Manolagas SC, Parfitt AM. What old means to bone. Trends Endocrinol Metab. 2010;21:369-374.
22. Almeida M, Han L, Martin-Millan M, et al. Skeletal involution by age-associated oxidative stress and its acceleration by loss of sex steroids. J Biol Chem. 2007;282:27285-27297.
23. Almeida M, Han L, Ambrogini E, Bartell SM, Manolagas SC. Oxidative stress stimulates apoptosis and activates NF-ΚB in osteoblastic cells via a PKCβ;/p66shc signaling cascade: counter regulation by estrogens or androgens. Mol Endocrinol. 2010;24:2030-2037.
24. Lean JM, Davies JT, Fuller K, et al. A crucial role for thiol antioxidants in estrogen-deficiency bone loss. J Clin Invest. 2003;112: 915-923.
25. Grassi F, Tell G, Robbie-Ryan M, et al. Oxidative stress causes bone loss in estrogen-deficient mice through enhanced bone marrow dendritic cell activation. Proc Natl Acad Sci USA. 2007;104: 15087-15092.
26. Almeida M, Martin-Millan M, Ambrogini E, et al. Estrogens attenuate oxidative stress, osteoblast differentiation and apoptosis by DNA binding-independent actions of the ERα. J Bone Miner Res. 2010;25:769-781.
27. Harrington WR, Kim SH, Funk CC, et al. Estrogen dendrimer conjugates that preferentially activate extranuclear, nongenomic versus genomic pathways of estrogen action. Mol Endocrinol. 2006;20: 491-502.
28. Kim SH, Katzenellenbogen JA. Hormone-PAMAM dendrimer conjugates: polymer dynamics and tether structure affect ligand access to receptors. Angew Chem Int Ed Engl. 2006;45:7243-7248.
29. Kukowska-Latallo JF, Candido KA, Cao Z, et al. Nanoparticle targeting of anticancer drug improves therapeutic response in animal model of human epithelial cancer. Cancer Res. 2005;65:5317- 5324.
30. Wu G, Barth RF, Yang W, Kawabata S, Zhang L, Green-Church K. Targeted delivery of methotrexate to epidermal growth factor receptor-positive brain tumors by means of cetuximab (IMC-C225) dendrimer bioconjugates. Mol Cancer Ther. 2006;5:52-59.
31. Chambliss KL, Wu Q, Oltmann S, et al. Non-nuclear estrogen receptor alpha signaling promotes cardiovascular protection but not uterine or breast cancer growth in mice. J Clin Invest. 2010;120: 2319-2330.
32. O'Brien CA, Jilka RL, Fu Q, Stewart S, Weinstein RS, Manolagas SC. IL-6 is not required for parathyroid hormone stimulation of RANKL expression, osteoclast formation, and bone loss in mice. Am J Physiol Endocrinol Metab. 2005;289:E784-E793.
33. Jilka RL, Almeida M, Ambrogini E, Han L, Roberson PK, Weinstein RS, Manolagas SC. Decreased oxidative stress and greater bone anabolism in the aged, as compared to the young, murine skeleton by parathyroid hormone. Aging Cell. 2010;9:851-867.
34. Bouxsein ML, Boyd SK, Christiansen BA, Guldberg RE, Jepsen KJ, Muller R. Guidelines for assessment of bone microstructure in rodents using micro-computed tomography. J Bone Miner Res. 2010; 25:1468-1486.
35. DiGregorio G, Yamamoto M, Ali A, Abe E, Roberson P, Manolagas SC, Jilka RL. Attenuation of the self-renewal of transit amplifying osteoblast progenitors in the murine bone marrow by 17β;estradiol. J Clin Invest. 2001;107:803-812.
36. Kuznetsov S, Robey PG. Species differences in growth requirements for bone marrow stromal fibroblast colony formation in vitro. Calcif Tissue Int. 1996;59:265-270.
37. Almeida M, Han L, Bellido T, Manolagas SC, Kousteni S. Wnt proteins prevent apoptosis of both uncommitted osteoblast progenitors and differentiated osteoblasts by β;-catenin-dependent and -independent signaling cascades involving Src/ERK and phosphatidylinositol 3-kinase/AKT. J Biol Chem. 2005;280:41342-41351.
38. -δδCT method. Methods. 2001;25:402-408.
39. Plotkin LI, Weinstein RS, Parfitt AM, Roberson PK, Manolagas SC, Bellido T. Prevention of osteocyte and osteoblast apoptosis by bisphosphonates and calcitonin. J Clin Invest. 1999;104:1363-1374.
40. Kousteni S, Almeida M, Han L, Bellido T, Jilka RL, Manolagas SC. Induction of osteoblast differentiation by selective activation of kinase-mediated actions of the estrogen receptor. Mol Cell Biol. 2007;27:1516-1530.
41. Callewaert F, Sinnesael M, Gielen E, Boonen S, Vanderschueren D. Skeletal sexual dimorphism: relative contribution of sex steroids, GH--IGF1, and mechanical loading. J Endocrinol. 2010;207:127-134.
42. Tobias JH, Chow J, Colston KW, Chambers TJ. High concentrations of 17β;-estradiol stimulate trabecular bone formation in adult female rats. Endocrinology. 1991;128:408-412.
43. Samuels A, Perry MJ, Goodship AE, Fraser WD, Tobias JH. Is high-dose estrogen-induced osteogenesis in the mouse mediated by an estrogen receptor? Bone. 2000;27:41-46.
44. Onal M, Xiong J, Chen X, et al. Receptor activator of nuclear factor ΚB Ligand (RANKL) protein expression by B lymphocytes contributes to ovariectomy-induced bone loss. J Biol Chem. 2012;287: 29851-29860.
45. Zebaze RM, Ghasem-Zadeh A, Bohte A, et al. Intracortical remodelling and porosity in the distal radius and post-mortem femurs of women: a cross-sectional study. Lancet. 2010;375:1729-1736.